Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples